Northland Capmk Forecasts Arteris’ Q1 Earnings (NASDAQ:AIP)

Arteris, Inc. (NASDAQ:AIP) – Equities research analysts at Northland Capmk decreased their Q1 2025 earnings per share (EPS) estimates for Arteris in a note issued to investors on Wednesday, February 19th. Northland Capmk analyst G. Richard now anticipates that the company will post earnings of ($0.21) per share for the quarter, down from their previous forecast of ($0.17). The consensus estimate for Arteris’ current full-year earnings is ($0.73) per share. Northland Capmk also issued estimates for Arteris’ Q2 2025 earnings at ($0.19) EPS, Q3 2025 earnings at ($0.17) EPS, Q4 2025 earnings at ($0.15) EPS, FY2025 earnings at ($0.71) EPS and FY2026 earnings at ($0.42) EPS.

Arteris (NASDAQ:AIP) last issued its quarterly earnings data on Tuesday, February 18th. The company reported ($0.19) EPS for the quarter, missing the consensus estimate of ($0.11) by ($0.08). Arteris had a negative return on equity of 828.71% and a negative net margin of 58.27%. The firm had revenue of $15.49 million during the quarter, compared to the consensus estimate of $15.34 million.

AIP has been the subject of a number of other research reports. Rosenblatt Securities reaffirmed a “buy” rating and issued a $15.00 price objective on shares of Arteris in a research note on Tuesday, February 18th. Northland Securities boosted their target price on Arteris from $14.00 to $16.00 and gave the stock an “outperform” rating in a research report on Wednesday, February 19th.

Arteris Stock Performance

NASDAQ:AIP opened at $8.89 on Monday. The stock has a 50-day simple moving average of $10.50 and a two-hundred day simple moving average of $8.78. Arteris has a 52-week low of $5.76 and a 52-week high of $12.64. The company has a debt-to-equity ratio of 0.30, a quick ratio of 1.17 and a current ratio of 1.17. The firm has a market capitalization of $364.05 million, a PE ratio of -10.22 and a beta of 1.18.

Institutional Trading of Arteris

Several hedge funds and other institutional investors have recently bought and sold shares of the stock. US Bancorp DE boosted its position in Arteris by 29.0% during the 4th quarter. US Bancorp DE now owns 5,702 shares of the company’s stock valued at $58,000 after acquiring an additional 1,283 shares in the last quarter. American Century Companies Inc. lifted its position in Arteris by 6.0% during the 4th quarter. American Century Companies Inc. now owns 30,357 shares of the company’s stock worth $309,000 after acquiring an additional 1,731 shares during the period. EntryPoint Capital LLC lifted its holdings in shares of Arteris by 14.0% in the 4th quarter. EntryPoint Capital LLC now owns 19,814 shares of the company’s stock valued at $202,000 after buying an additional 2,430 shares during the period. Charles Schwab Investment Management Inc. lifted its holdings in shares of Arteris by 4.4% in the 4th quarter. Charles Schwab Investment Management Inc. now owns 78,690 shares of the company’s stock valued at $802,000 after buying an additional 3,298 shares during the period. Finally, Wells Fargo & Company MN lifted its holdings in shares of Arteris by 38.9% in the 4th quarter. Wells Fargo & Company MN now owns 13,192 shares of the company’s stock valued at $134,000 after buying an additional 3,694 shares during the period. Institutional investors own 64.36% of the company’s stock.

Insider Transactions at Arteris

In related news, VP Paul L. Alpern sold 2,471 shares of the stock in a transaction that occurred on Thursday, January 2nd. The stock was sold at an average price of $11.41, for a total value of $28,194.11. Following the transaction, the vice president now owns 64,930 shares of the company’s stock, valued at $740,851.30. This represents a 3.67 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, Director Isabelle F. Geday sold 15,550 shares of the stock in a transaction that occurred on Wednesday, December 4th. The stock was sold at an average price of $9.03, for a total value of $140,416.50. Following the completion of the transaction, the director now directly owns 121,213 shares in the company, valued at approximately $1,094,553.39. This trade represents a 11.37 % decrease in their position. The disclosure for this sale can be found here. Over the last three months, insiders have sold 367,157 shares of company stock worth $3,828,388. 33.70% of the stock is currently owned by company insiders.

Arteris Company Profile

Arteris, Inc provides semiconductor interconnect intellectual property (IP) and System-on-Chip (Soc) Integration Automation software solutions (SIA) in the Americas, the Asia Pacific, Europe, and the Middle East. The company develops, licenses, and supports the on-chip interconnect fabric technology used in Soc designs and Network-on-Chip (NoC) interconnect IP.